| 1 | Study | 1.8% | |
| 2 | Health | 1.07% | |
| 3 | Case | 0.9% | |
| 4 | Report | 0.78% | |
| 5 | Patients | 0.75% | |
| 6 | Risk | 0.67% | |
| 7 | Disease | 0.67% | |
| 8 | Cancer | 0.64% | |
| 9 | New | 0.55% | |
| 10 | May | 0.43% | |
| 11 | Brain | 0.43% | |
| 12 | Heart | 0.43% | |
| 13 | Diabetes | 0.43% | |
| 14 | HIV | 0.38% | |
| 15 | Treatment | 0.38% | |
| 16 | Linked | 0.38% | |
| 17 | Therapy | 0.38% | |
| 18 | Patient | 0.35% | |
| 19 | Chronic | 0.35% | |
| 20 | Review | 0.32% | |
| 21 | Syndrome | 0.32% | |
| 22 | Blood | 0.32% | |
| 23 | Acute | 0.32% | |
| 24 | Times | 0.32% | |
| 25 | AI | 0.32% | |
| 26 | FDA | 0.29% | |
| 27 | Finds | 0.29% | |
| 28 | Pediatric | 0.26% | |
| 29 | Management | 0.26% | |
| 30 | Hindustan | 0.26% | |
| 31 | Care | 0.26% | |
| 32 | Failure | 0.23% | |
| 33 | Use | 0.23% | |
| 34 | Type | 0.23% | |
| 35 | According | 0.23% | |
| 36 | Diagnosis | 0.23% | |
| 37 | Prevalence | 0.23% | |
| 38 | Rates | 0.23% | |
| 39 | Lower | 0.23% | |
| 40 | Improve | 0.23% | |
| 41 | Africa | 0.2% | |
| 42 | Liver | 0.2% | |
| 43 | mRNA | 0.2% | |
| 44 | Over | 0.2% | |
| 45 | Pain | 0.2% | |
| 46 | Cell | 0.2% | |
| 47 | Systematic | 0.17% | |
| 48 | Coronary | 0.17% | |
| 49 | Artery | 0.17% | |
| 50 | Young | 0.17% | |
|
는 분류, 데이터 기준으로 의 기사에서 의 고유명사 데이터를 통해 생성되었습니다.
|
|||
Investigational Therapy TAK-861 Reduces Microsleeps in Phase 2 Trial of Narcolepsy Type 1
NeurologyLive
2025-06-11 02:05:59
Samelisant Significantly Reduces Excessive Daytime Sleepiness in Phase 2 Narcolepsy Study
NeurologyLive
2025-06-09 04:02:16